Integrating biophysics with HTS-driven drug discovery projects

被引:34
作者
Folmer, Rutger H. A. [1 ]
机构
[1] AstraZeneca R&D, Discovery Sci, Dept Struct & Biophys, SE-43183 Molndal, Sweden
关键词
HIGH-THROUGHPUT; LIGAND-BINDING; HIT VALIDATION; NMR; PROTEIN; INHIBITORS; KINETICS; QUALITY; DETECT; ASSAYS;
D O I
10.1016/j.drudis.2016.01.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past decade biophysics has become an established discipline in HTS hit triaging, owing to its high fidelity in detecting protein-ligand interactions. Many pharma companies are using biophysical techniques to filter HTS output for false positives, as will be discussed in this review. Moreover, I will demonstrate how the earlier application of biophysics, already at the HTS assay development stage, is potentially even more impactful. Two key areas here are early mode-of-action studies and ensuring that the HTS assay and subsequent cascade are fit for purpose. Top-level results from 20 in-house projects are shown to underpin the impact of these studies.
引用
收藏
页码:491 / 498
页数:8
相关论文
共 31 条
[1]   Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads [J].
Bergsdorf, Christian ;
Ottl, Johannes .
EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (11) :1095-1107
[2]   Free-solution, label-free molecular interactions studied by back-scattering interferometry [J].
Bornhop, Darryl J. ;
Latham, Joey C. ;
Kussrow, Amanda ;
Markov, Dmitry A. ;
Jones, Richard D. ;
Sorensen, Henrik S. .
SCIENCE, 2007, 317 (5845) :1732-1736
[3]  
Ciulli Alessio, 2013, Methods Mol Biol, V1008, P357, DOI 10.1007/978-1-62703-398-5_13
[4]   Pharmacokinetics and the drug-target residence time concept [J].
Dahl, Goran ;
Akerud, Tomas .
DRUG DISCOVERY TODAY, 2013, 18 (15-16) :697-707
[5]  
Dahlin JL, 2014, FUTURE MED CHEM, V6, P1265, DOI [10.4155/fmc.14.60, 10.4155/FMC.14.60]
[6]   Fragment screening to predict druggability (ligandability) and lead discovery success [J].
Edfeldt, Fredrik N. B. ;
Folmer, Rutger H. A. ;
Breeze, Alexander L. .
DRUG DISCOVERY TODAY, 2011, 16 (7-8) :284-287
[7]   HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase [J].
Evenas, Johan ;
Edfeldt, Fredrik ;
Lepisto, Matti ;
Svitacheva, Naila ;
Synnergren, Anna ;
Lundquist, Britta ;
Granse, Mia ;
Ronnholm, Anna ;
Varga, Mikael ;
Wright, John ;
Wei, Min ;
Yue, Sherrie ;
Wang, Junfeng ;
Li, Chong ;
Li, Xuan ;
Chen, Gang ;
Liao, Yong ;
Lv, Gang ;
Tjornebo, Ann ;
Narjes, Frank .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (05) :1315-1321
[8]  
Fang Y, 2006, BIOPHYS J, V91, P1925, DOI 10.1529/biophysj.105.007818
[9]   Live Cell NMR [J].
Freedberg, Daron I. ;
Selenko, Philipp .
ANNUAL REVIEW OF BIOPHYSICS, VOL 43, 2014, 43 :171-192
[10]   Applications of Biophysics in High-Throughput Screening Hit Validation [J].
Genick, Christine Clougherty ;
Barlier, Danielle ;
Monna, Dominique ;
Brunner, Reto ;
Be, Celine ;
Scheufler, Clemens ;
Ottl, Johannes .
JOURNAL OF BIOMOLECULAR SCREENING, 2014, 19 (05) :707-714